{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:48:47Z","timestamp":1792597727096,"version":"4.5.0"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:00:00Z","timestamp":1307232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00005-011-0130-5","type":"journal-article","created":{"date-parts":[[2011,6,4]],"date-time":"2011-06-04T13:42:16Z","timestamp":1307194936000},"page":"239-247","source":"Crossref","is-referenced-by-count":37,"title":["Recent Progress of Shiga Toxin Neutralizer for Treatment of Infections by Shiga Toxin-Producing Escherichia coli"],"prefix":"10.2478","volume":"59","author":[{"given":"Kiyotaka","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2011,6,5]]},"reference":[{"key":"130_CR1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/infdis\/164.6.1160","volume":"164","author":"GD Armstrong","year":"1991","unstructured":"Armstrong GD, Fodor E, Vanmaele R (1991) Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J Infect Dis 164:1160\u20131167","journal-title":"J Infect Dis"},{"key":"130_CR2","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1073\/pnas.84.13.4364","volume":"84","author":"SB Calderwood","year":"1987","unstructured":"Calderwood SB, Auclair F, Donohue-Rolfe A et al (1987) Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc Natl Acad Sci USA 84:4364\u20134368","journal-title":"Proc Natl Acad Sci USA"},{"key":"130_CR3","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1128\/jb.169.9.4313-4319.1987","volume":"169","author":"S DeGrandis","year":"1987","unstructured":"DeGrandis S, Ginsberg J, Toone M et al (1987) Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J Bacteriol 169:4313\u20134319","journal-title":"J Bacteriol"},{"key":"130_CR4","doi-asserted-by":"crossref","first-page":"12520","DOI":"10.1016\/S0021-9258(18)63888-8","volume":"264","author":"S DeGrandis","year":"1989","unstructured":"DeGrandis S, Law H, Brunton J et al (1989) Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem 264:12520\u201312525","journal-title":"J Biol Chem"},{"key":"130_CR5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1086\/315421","volume":"181","author":"A Donohue-Rolfe","year":"2000","unstructured":"Donohue-Rolfe A, Kondova I, Oswald S et al (2000) Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J Infect Dis 181:1825\u20131829","journal-title":"J Infect Dis"},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"27511","DOI":"10.1074\/jbc.M401939200","volume":"279","author":"ME Fraser","year":"2004","unstructured":"Fraser ME, Fujinaga M, Cherney MM et al (2004) Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem 279:27511\u201327517","journal-title":"J Biol Chem"},{"key":"130_CR7","first-page":"331","volume":"52","author":"VP Gannon","year":"1988","unstructured":"Gannon VP, Gyles CL, Friendship RW (1988) Characteristics of verotoxigenic Escherichia coli from pigs. Can J Vet Res 52:331\u2013337","journal-title":"Can J Vet Res"},{"issue":"13 suppl","key":"130_CR8","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.2527\/jas.2006-508","volume":"85","author":"CL Gyles","year":"2007","unstructured":"Gyles CL (2007) Shiga toxin-producing Escherichia coli: an overview. J Anim Sci 85(13 suppl):E45\u2013E62","journal-title":"J Anim Sci"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1574-6968.1987.tb02252.x","volume":"44","author":"MP Jackson","year":"1987","unstructured":"Jackson MP, Neill RJ, O\u2019Brien AD et al (1987a) Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett 44:109\u2013114","journal-title":"FEMS Microbiol Lett"},{"key":"130_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0882-4010(87)90106-9","volume":"2","author":"MP Jackson","year":"1987","unstructured":"Jackson MP, Newland JW, Holmes RK et al (1987b) Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933\u00a0J from Escherichia coli. Microb Pathog 2:147\u2013153","journal-title":"Microb Pathog"},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","volume":"1","author":"MA Karmali","year":"1983","unstructured":"Karmali MA, Steele BT, Petric M et al (1983) Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet 1:619\u2013620","journal-title":"Lancet"},{"key":"130_CR12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","volume":"151","author":"MA Karmali","year":"1985","unstructured":"Karmali MA, Petric M, Lim C et al (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775\u2013782","journal-title":"J Infect Dis"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"41576","DOI":"10.1074\/jbc.M107819200","volume":"276","author":"T Kimura","year":"2001","unstructured":"Kimura T, Tani S, Matsumoto Y et al (2001) Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood. J Biol Chem 276:41576\u201341579","journal-title":"J Biol Chem"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/35001095","volume":"403","author":"PI Kitov","year":"2000","unstructured":"Kitov PI, Sadowska JM, Mulvey G et al (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403:669\u2013672","journal-title":"Nature"},{"key":"130_CR15","doi-asserted-by":"crossref","first-page":"16837","DOI":"10.1073\/pnas.0804919105","volume":"105","author":"PI Kitov","year":"2008","unstructured":"Kitov PI, Mulvey GL, Griener TP et al (2008) In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins. Proc Natl Acad Sci USA 105:16837\u201316842","journal-title":"Proc Natl Acad Sci USA"},{"key":"130_CR16","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1074\/jbc.275.5.3713","volume":"275","author":"JF Kokai-Kun","year":"2000","unstructured":"Kokai-Kun JF, Melton-Celsa AR, O\u2019Brien AD (2000) Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem 275:3713\u20133721","journal-title":"J Biol Chem"},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-1119(88)90398-8","volume":"67","author":"YV Kozlov","year":"1988","unstructured":"Kozlov YV, Kabishev AA, Lukyanov EV et al (1988) The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 Shiga-like toxin. Gene 67:213\u2013221","journal-title":"Gene"},{"key":"130_CR18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bi971806n","volume":"37","author":"H Ling","year":"1998","unstructured":"Ling H, Boodhoo A, Hazes B et al (1998) Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37:1777\u20131788","journal-title":"Biochemistry"},{"key":"130_CR19","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1016\/S0040-4039(99)01632-9","volume":"40","author":"K Matsuoka","year":"1999","unstructured":"Matsuoka K, Terabatake M, Esumi Y et al (1999) Synthetic assembly of trisaccharide moieties of globotriaosyl ceramide using carbosilane dendrimers as cores. A new type of functional glyco-material. Tetrahedron Lett 40:7839\u20137842","journal-title":"Tetrahedron Lett"},{"key":"130_CR20","unstructured":"Melton-Celsa AR, O\u2019Brien AD (1998) Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals. In: Kaper JB, O\u2019Brien AD (eds) Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. Am Soc Microbiol, Washington, pp 121\u2013128"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/373996","volume":"187","author":"GL Mulvey","year":"2003","unstructured":"Mulvey GL, Marcato P, Kitov PI et al (2003) Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J Infect Dis 187:640\u2013649","journal-title":"J Infect Dis"},{"key":"130_CR22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1097-2765(05)00085-7","volume":"6","author":"K Nishikawa","year":"2000","unstructured":"Nishikawa K, Sawasdikosol S, Fruman DA et al (2000) A peptide library approach identifies a specific inhibitor for the ZAP-70 protein tyrosine kinase. Mol Cell 6:969\u2013974","journal-title":"Mol Cell"},{"key":"130_CR23","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1073\/pnas.112058999","volume":"99","author":"K Nishikawa","year":"2002","unstructured":"Nishikawa K, Matsuoka K, Kita E et al (2002) A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc Natl Acad Sci USA 99:7669\u20137674","journal-title":"Proc Natl Acad Sci USA"},{"key":"130_CR24","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1086\/430388","volume":"191","author":"K Nishikawa","year":"2005","unstructured":"Nishikawa K, Matsuoka K, Watanabe M et al (2005) Identification of the optimal structure for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. J Infect Dis 191:2097\u20132105","journal-title":"J Infect Dis"},{"key":"130_CR25","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1096\/fj.06-6572fje","volume":"20","author":"K Nishikawa","year":"2006","unstructured":"Nishikawa K, Watanabe M, Kita E et al (2006) A multivalent peptide-library approach identifies a novel Shiga toxin-inhibitor that induces aberrant cellular transport of the toxin. FASEB J 20:2597\u20132599","journal-title":"FASEB J"},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1074-5521(96)90106-4","volume":"3","author":"PG Nyholm","year":"1996","unstructured":"Nyholm PG, Magnusson G, Zheng Z et al (1996) Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol 3:263\u2013275","journal-title":"Chem Biol"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/MMBR.51.2.206-220.1987","volume":"51","author":"AD O\u2019Brien","year":"1987","unstructured":"O\u2019Brien AD, Holmes RK (1987) Shiga and Shiga-like toxins. Microbiol Rev 51:206\u2013220","journal-title":"Microbiol Rev"},{"key":"130_CR28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/160.6.994","volume":"160","author":"SM Ostroff","year":"1989","unstructured":"Ostroff SM, Tarr PI, Neill MA et al (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160:994\u2013998","journal-title":"J Infect Dis"},{"key":"130_CR29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.11.3.450","volume":"11","author":"JC Paton","year":"1998","unstructured":"Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450\u2013479","journal-title":"Clin Microbiol Rev"},{"key":"130_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/73111","volume":"6","author":"AW Paton","year":"2000","unstructured":"Paton AW, Morona R, Paton JC (2000) A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat Med 6:265\u2013270","journal-title":"Nat Med"},{"key":"130_CR31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/IAI.69.3.1967-1970.2001","volume":"69","author":"AW Paton","year":"2001","unstructured":"Paton AW, Morona R, Paton JC (2001a) Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect Immun 69:1967\u20131970","journal-title":"Infect Immun"},{"key":"130_CR32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1128\/IAI.69.3.1389-1393.2001","volume":"69","author":"JC Paton","year":"2001","unstructured":"Paton JC, Rogers TJ, Morona R et al (2001b) Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli. Infect Immun 69:1389\u20131393","journal-title":"Infect Immun"},{"key":"130_CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrmicro1349","volume":"4","author":"AW Paton","year":"2006","unstructured":"Paton AW, Morona R, Paton JC (2006) Designer probiotics for prevention of enteric infections. Nat Rev Microbiol 4:193\u2013200","journal-title":"Nat Rev Microbiol"},{"key":"130_CR34","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JCM.36.11.3317-3322.1998","volume":"36","author":"D Pi\u00e9rard","year":"1998","unstructured":"Pi\u00e9rard D, Muyldermans G, Moriau L et al (1998) Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 36:3317\u20133322","journal-title":"J Clin Microbiol"},{"key":"130_CR35","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/IAI.60.10.4154-4167.1992","volume":"60","author":"SE Richardson","year":"1992","unstructured":"Richardson SE, Rotman TA, Jay V et al (1992) Experimental verocytotoxemia in rabbits. Infect Immun 60:4154\u20134167","journal-title":"Infect Immun"},{"key":"130_CR36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM198303243081203","volume":"308","author":"LW Riley","year":"1983","unstructured":"Riley LW, Remis RS, Helgerson SD et al (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308:681\u2013685","journal-title":"N Engl J Med"},{"key":"130_CR37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/IAI.58.3.611-618.1990","volume":"58","author":"JE Samuel","year":"1990","unstructured":"Samuel JE, Perera LP, Ward S et al (1990) Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun 58:611\u2013618","journal-title":"Infect Immun"},{"key":"130_CR38","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1093\/emboj\/19.22.5943","volume":"19","author":"K Sandvig","year":"2000","unstructured":"Sandvig K, van Deurs B (2000) Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J 19:5943\u20135950","journal-title":"EMBO J"},{"key":"130_CR39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/358510a0","volume":"358","author":"K Sandvig","year":"1992","unstructured":"Sandvig K, Garred O, Prydz K et al (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510\u2013512","journal-title":"Nature"},{"key":"130_CR40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/AEM.66.3.1205-1208.2000","volume":"66","author":"H Schmidt","year":"2000","unstructured":"Schmidt H, Scheef J, Morabito S et al (2000) A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol 66:1205\u20131208","journal-title":"Appl Environ Microbiol"},{"key":"130_CR41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/IAI.59.3.1065-1073.1991","volume":"59","author":"CK Schmitt","year":"1991","unstructured":"Schmitt CK, McKee ML, O\u2019Brien AD (1991) Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun 59:1065\u20131073","journal-title":"Infect Immun"},{"key":"130_CR42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00467-002-1035-7","volume":"18","author":"RL Siegler","year":"2003","unstructured":"Siegler RL, Obrig TG, Pysher TJ et al (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92\u201396","journal-title":"Pediatr Nephrol"},{"key":"130_CR43","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1074\/jbc.M107472200","volume":"277","author":"AM Soltyk","year":"2002","unstructured":"Soltyk AM, MacKenzie CR, Wolski VM et al (2002) A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1. J Biol Chem 277:5351\u20135359","journal-title":"J Biol Chem"},{"key":"130_CR44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","volume":"141","author":"B Stechmann","year":"2010","unstructured":"Stechmann B, Bai SK, Gobbo E et al (2010) Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141:231\u2013242","journal-title":"Cell"},{"key":"130_CR45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/jb.170.3.1116-1122.1988","volume":"170","author":"NA Strockbine","year":"1988","unstructured":"Strockbine NA, Jackson MP, Sung LM et al (1988) Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 170:695\u2013700","journal-title":"J Bacteriol"},{"key":"130_CR46","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/IAI.61.8.3392-3402.1993","volume":"61","author":"VL Tesh","year":"1993","unstructured":"Tesh VL, Burris JA, Owens JW et al (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392\u20133402","journal-title":"Infect Immun"},{"key":"130_CR47","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","volume":"290","author":"H Trachtman","year":"2003","unstructured":"Trachtman H, Cnaan A, Christen E et al (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290:1337\u20131344","journal-title":"JAMA"},{"key":"130_CR48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/381124","volume":"189","author":"M Watanabe","year":"2004","unstructured":"Watanabe M, Matsuoka K, Kita E et al (2004) Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. J Infect Dis 189:360\u2013368","journal-title":"J Infect Dis"},{"key":"130_CR49","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/IAI.74.3.1984-1988.2006","volume":"74","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Igai K, Matsuoka K et al (2006) Structural analysis of the interaction between Shiga toxin B-subunits and linear polymers bearing clustered globotriose residues. Infect Immun 74:1984\u20131988","journal-title":"Infect Immun"},{"key":"130_CR50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/IAI.01022-09","volume":"78","author":"M Watanabe-Takahashi","year":"2010","unstructured":"Watanabe-Takahashi M, Sato T, Dohi T et al (2010) An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin. Infect Immun 78:177\u2013183","journal-title":"Infect Immun"},{"key":"130_CR51","first-page":"1309","volume":"133","author":"GA Willshaw","year":"1987","unstructured":"Willshaw GA, Smith HR, Scotland SM et al (1987) Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol 133:1309\u20131317","journal-title":"J Gen Microbiol"},{"key":"130_CR52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-6968.1987.tb02555.x","volume":"48","author":"T Yutsudo","year":"1987","unstructured":"Yutsudo T, Kurazono H, Sasakawa C et al (1987) Cloning of a Vero toxin (VT2) gene from a VT2-converting phage isolated from Escherichia coli 0157:H7. FEMS Microbiol Lett 48:273\u2013276","journal-title":"FEMS Microbiol Lett"},{"key":"130_CR53","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JCM.40.4.1441-1446.2002","volume":"40","author":"W Zhang","year":"2002","unstructured":"Zhang W, Bielaszewska M, Kuczius T et al (2002) Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans. J Clin Microbiol 40:1441\u20131446","journal-title":"J Clin Microbiol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-011-0130-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-011-0130-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-011-0130-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:47:17Z","timestamp":1704228437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-011-0130-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,5]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s00005-011-0130-5","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,5]]}}}